Share This Article with a Friend!

Americans will bear the full cost of the nearly ready Wuhan virus vaccine

R. Emmett Tyrrell, Jr., The American Spectator

Almost all companies developing a vaccine are in the U.S. Here the free market is sufficiently intact to grant us the benefits of markets. Those would be innovation, speedy testing, and plenty of resources for research and development. The bad news is Americans will pay the full cost of developing these vaccines for COVID-19. No one else will step in. The rest of the world will get what America has developed and they will get it at bargain prices. The reason? Most countries have fully-or mostly-socialized their health care, and the price they establish for pharmaceuticals reflects that.